Peritoneal dialysis (PD) in infants represents one of the greatest challenges for pediatric nephrologists. Over recent years, positive outcome data described by several multicenter experiences and registry studies have increased the amount of information available to help determine whether to initiate a dialysis program in this high-risk patient population. There is no doubt that the rigorous implementation of strategies aimed at preventing infectious complications may have contributed to reducing the morbidity rate of these patients. However, the complex nature of infants with end-stage renal disease and the presence of multiple comorbidities still represent hallmarks that significantly impact on outcome. Although the rigorous application of improved scientific techniques can still contribute to enhancing PD results in infants, we have to acknowledge that the severity of illness in infants, especially at dialysis initiation, represents an undeniable and nonmodifiable factor.
Introduction
An increasing number of publications in recent years have reported satisfactory outcomes with respect to morbidity, mortality, growth, and development in newborns and infants undergoing maintenance peritoneal dialysis (PD) [1] [2] [3] [4] [5] . A very young age at dialysis initiation still has a negative prognostic value, but this alone cannot remain a contraindication to any form of renal replacement therapy (RRT). As a consequence, an increasing number of infants are successfully treated with PD, and the question has shifted from whether or not to start dialysis to how to improve dialysis management in these fragile patients.
According to the most recent European Registry for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry Annual Report, in 2015, the number of children with end stage renal disease (ESRD) in whom hemodialysis (HD) (41.6%) and PD (39.5%) was initiated was similar [6] .
However, in small children, PD still represents the dialysis modality of choice [4] . Several studies indicate young age as a risk factor for infectious complications in children on dialysis. The most common complication associated with PD continues to be peritonitis, which is also the most frequent cause for hospitalization in children receiving PD [7, 8] . On the basis of previous studies describing infant dialysis, cohort-specific peritonitis incidence ranges from 0.58 to 1.7 episodes per patient-year [1] [2] [3] . In the last annual report of the North American Pediatric Renal Trials and Collaborative studies (NAPRTCS), which includes data collected over a 20-year period, 4248 episodes of peritonitis in 6658 patient-years of follow-up were reported, yielding an annualized rate of 0.64, or one episode every 18.8 months [9] . The annualized rate decreases with patient age, with the youngest (<1 year) having an annualized rate of 0.79 and those older than 12 years 0.57. Occurrence of peritonitis is associated with high mortality and can also impact on the structure and function of the peritoneal membrane, thus reducing long-term availability of effective dialysis [7, 8] . Several risk factors can influence the incidence of peritonitis in children, and understanding them is important to optimize prevention and patient outcome. Quality of care received by children on dialysis is essential to minimize long-term complications, and this concept is especially true in infants, who will have a lifetime of RRT ahead of them.
What we know
Evidence derived from several registry-based studies has identified factors potentially associated with peritonitis in children on PD. Recognized risk factors are touch contamination, exit site/tunnel infection [10] , catheter leakage, oligoanuria [2, 11] , and presence of nasogastric tube/gastrostomy [3, 12] . Surgical expertise and antibiotic prophylaxis are keys to minimizing the risks associated with early-onset peritonitis after PD catheter insertion [13] . The risk for developing peritonitis associated with these factors is emphasized during infancy. The catheter design associated with a lower risk of infection in children appears to be the double-cuffed swan-neck catheter with its inherent downward-directed exit site [13] . However, infants with limited abdominal wall, particularly if hypoproteinemic, are at risk of distal cuff extrusion [14] , with a subsequent higher risk of leakage, exit site infection, and eventually peritonitis. This risk can be reduced by delaying dialysis onset to 2-3 weeks after implantation and by monitoring intraperitoneal pressure [15, 16] . Concerns also exist that a downward exit site may be a risk factor for infections in small children using diapers. The proximity of the catheter exit site to the diaper region or to gastrostomy/vesicostomy/ nephrostomy sites has been associated with higher incidence of Gram-negative peritonitis (diaper peritonitis) compared with older children [17] . In some centers, this issue has been successfully addressed by placing the exit site outside the diaper area, in the presternal area [18] .
Nutritional management is an essential part of the care of small children receiving dialysis, and tube feeding of infants on PD is mandatory to achieve their growth potential [19] . However, the use of gastrostomy tube/button impacts on the risk for peritonitis. Ledermann et al. reported that the incidence of peritonitis in their gastrostomy-fed infants was twice as great when tube insertion was conducted after, compared with before, dialysis initiation [12] . When supplemental tube feeding is considered likely, prior or concurrent placement of a gastrostomy at the time of PD catheter placement, with appropriate antibiotic and antifungal prophylaxis, decreases the risk of bacterial or fungal infections that can occur soon after PD catheter placement [13] . Percutaneous placement of a gastrostomy tube while on PD should not be performed due to the high risk of infections and mechanical failure [20] .
Infants on chronic PD with oliguria frequently have hypoproteinemia and hypogammaglobulinemia as a result of malnutrition and peritoneal protein losses [2] . The presence of hypogammaglobulinemia is commonly complicated by the development of recurrent infections and, specifically, might be a risk factor for the development of bacterial peritonitis in patients receiving PD. There is no evidence for routine IV administration of prophylactic immunoglobulins in all infants [21] , but replacement therapy should be considered if very low immunoglobulin levels are found [22, 23] .
Hospitalization rates for infants on PD are higher than those for older children [2] . In a NAPRTCS analysis, Carey et al. demonstrated that~75% of children <2 years required hospitalization while on maintenance dialysis [24] . The last Annual Report of the United States Renal Data System (USRDS) clearly demonstrated an increase in all-cause hospitalization rates of children with ESRD from 2003 to 2007 to 2008-2012 [25] . During the more recent time frame, the rates of 1-year hospitalization were highest in PD patients (2189 admissions per 1000 patient-years) and in the youngest segment of children with ESRD (0-4 years, 3253 admissions per 1000 patient-years). Infection was the leading cause for hospitalization: in children 0-4 years of age, the overall rate of hospitalization [26] . The greater likelihood of longer hospitalization and the increased risk of complications potentially resulting in additional surgical procedures are factors that significantly impact the biological and economic cost of dialysis for infants. It follows that efforts should be directed to implement all strategies aimed at preventing and reducing peritonitis in infant PD, including using improved scientific models.
A new character: SCOPE collaborative
The concept of improvement science recently emerged and provides a framework for research focused on healthcare improvement. The overriding goal of improvement science is to ensure that quality-improvement efforts are based both on evidence and best-practice recommendations [27] . Improvement science methods have been used to reduce a variety of healthcare-associated infections in children. A program aimed at preventing peritonitis in children on PD should, therefore, focus on Bdrivers^known to be associated with PD infections, such as catheter insertion practices, pre-and postoperative care, exit-site management, recognition and treatment of touch contamination, exit-site and tunnel infection, education of dialysis staff, and patient and family engagement strategies [28] . The Children's Hospital Association's Standardizing Care to Improve Outcomes in Pediatric ESRD (SCOPE) Collaborative is a quality-improvement project aimed at reducing PD-associated infections in children on chronic PD, addressing, in a systematic fashion, most of the aforementioned drivers [29] . The objectives of this qualitytransformation effort were to evaluate whether providing compliance with a series of care practice bundles (encompassing PD catheter insertion, patient and caregiver training, and follow-up care) was associated with lower risk for peritonitis among pediatric patients on PD. In the first 3 years of the SCOPE Collaborative (1 October 2011 to 30 September 2014), 734 children with a median age of 9 years were enrolled; children <2 years represented 32.4% of the cohort [30] . About one third of patients enrolled (n = 245) developed at least one episode of peritonitis, resulting in an annualized peritonitis rate of 0.46 infections per patient-year. Providing compliance with the Btraining^bundles did not significantly differ between children with and without peritonitis. In contrast, compliance with the follow-up bundle, including reviewing key aspects of hand washing, exit-site care, and aseptic connection technique, resulted in a significantly lower risk of peritonitis. Overall, implementation of three standardized PD catheter-care bundles reduced the monthly annualized peritonitis rate from 0.63 pre-SCOPE Collaborative to 0.42 at 3 years postlaunch [31] . In univariate analysis, the peritonitis group had a significantly higher proportion of patients with gastrostomy tube, incontinence (e.g., in diapers), and report of touch contamination in the month before infection or at last follow-up compared with the group without peritonitis [30] .
Comparison of PD catheter characteristics revealed that the peritonitis group had significantly more catheters with upward (rather than downward or lateral) orientation at the exit-site and use of a plastic rather than titanium adapter at the distal end of the catheter [30] . Since its launch, it is estimated that the SCOPE Collaborative has prevented nearly 400 episodes of peritonitis, avoided 240 hospitalizations, and saved more than US$7 million in healthcare costs [32] . Moreover, the study confirmed that there is still the need and space to intervene against modifiable factors to reduce the burden of peritonitis in PD patients.
SCOPE collaborative and infants
In this issue of Pediatric Nephrology, using data from the SCOPE Collaborative, Zaritsky et al. examine the epidemiology of peritonitis in 156 infants who had a PD catheter placed in the first year of life [33] . Patients were enrolled at the time of catheter placement, even if chronic care had not been established as an outpatient. This means that the study also included patients who started chronic PD as an inpatient and remained hospitalized. Therefore, these data integrate information obtained from home-based registries and provide a more complete overview about epidemiology and risk factors for peritonitis and the outcome of infants on PD.
The study has three major findings that corroborate or provide new evidence as regards peritonitis in infants on PD. First, data from the SCOPE Collaborative confirm that the annualized peritonitis rates are very high in infants undergoing PD catheter insertion in their first year of life. Specifically, 65 of 156 infants (42%) had at least one episode of bacterial peritonitis within 1 year, resulting in an overall annualized rate of 0.76 episodes per patient-year. An extremely high incidence of peritonitis was observed early, during the initial hospital stay after PD catheter placement (1.73 episodes per patient-year).
Second, this uneven distribution of peritonitis rates among the same cohort of patients highlights that qualitatively and quantitatively different risk factors are associated with peritonitis in infants started (inpatients) or maintained (outpatients) on PD. Diagnosis of polycystic kidney disease-namely, autosomal recessive polycystic disease (ARPKD), history of pulmonary hypoplasia, the use of a curled PD catheter or plastic adaptor, nephrectomy prior to or concurrent with PD catheter insertion, and gastrostomy tube insertion after catheter placement-were significantly more common in patients who experienced peritonitis compared to those who did not. Infants with an episode of peritonitis during their initial hospitalization were younger and more likely to have a diagnosis of ARPKD and a history of pulmonary hypoplasia than those who developed peritonitis as outpatients. Moreover, most inhospital cases of peritonitis were associated with the need for nephrectomy. The relative lower incidence of outpatient peritonitis may reflect an exposure to fewer or less-severe risk factors in nonhospitalized infants but may also be due to the type of care patients received by staff and parents trained according to the SCOPE bundles. All variables that gave significant results in univariate analysis were then included in a multivariable logistic regression model. Because of multicollinearity, the only factors independently associated with increased risk of peritonitis in the whole cohort were nephrectomy and gastrostomy tube insertion after PD catheter placement. The last is the only true identified modifiable factor, while nephrectomy is perhaps a surrogate for the diagnosis of ARPKD, a condition associated with severe comorbidities, a higher risk of infection, and increased mortality rates. Unilateral or bilateral nephrectomy often represents an inevitable therapeutic approach to ameliorate respiratory impairment, nutritional management, and facilitate PD initiation.
Third, this study confirms that peritonitis is associated with increased morbidity. It also provides benchmarks for hospitalization in infants starting on PD to compare with other pediatric centers and with ourselves in the future. Infants have a long duration of hospitalization after PD initiation, ranging from a minimum of 60 days to a maximum of 154 days for patients who require nephrectomy, G-tube insertion after PD catheter placement, and with in-hospital peritonitis.
The study of Zaritsky et al. [33] provides new evidence on risk factors associated with the development of peritonitis in infants, especially as regards patients during their initial hospitalization and after PD catheter placement. However, because it was not included within the SCOPE Collaborative primary aims, the authors did not analyze risk for and incidence of other conditions, such as catheter-related (mechanical) or clinical complications.
Conclusions
Dialysis-access-associated infections, specifically peritonitis, are leading causes of hospitalization and death among infants receiving PD. The use of clinical practice improvement methods helps prevent infection and, when they occur, initiation of prompt and appropriate treatment, and thus should be included in pediatric PD programs. Infants who develop peritonitis early after PD implantation and while hospitalized have different clinical characteristics than those who only develop peritonitis as an outpatient. Inpatient peritonitis is more frequently associated with nonmodifiable risk factors, including diagnosis of ARPKD, comorbidities, and the need for nephrectomy.
